Role of opioid antagonists in treating intravenous cocaine abuse.
about
Cyclazocine revisitedDrugs of abuse--opiatesMethadone maintenance in the treatment of opioid dependence. A current perspective.EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIESPredicting response to opiate antagonists and placebo in the treatment of pathological gamblingInfluence of psychotherapy attendance on buprenorphine treatment outcome.Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependenceEffects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake.Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonismBuprenorphine withdrawal syndromeChronic daily ethanol and withdrawal: 3. Forebrain pro-opiomelanocortin gene expression and implications for dependence, relapse, and deprivation effect.Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.The Black Book of Psychotropic Dosing and Monitoring.18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.Naloxone-induced withdrawal in patients with buprenorphine dependence.Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.
P2860
Q28298711-D4E33B44-DE06-46D5-8809-90697B47840EQ33558223-A130BB73-4BC5-4545-B8CB-6280582D9F9DQ33558247-EE4C2541-41EF-4016-812F-4810E36CF12DQ34974629-C58F26F1-5C81-4D41-83B0-4E28B3E19E04Q36931279-4CB0A8C6-6F8B-4567-A8EC-1F34D6279D0EQ37079329-2DA4F7BB-850C-480E-BC04-DB6F4521540EQ37079346-8727F93A-13E9-498C-9895-44EDC7D6D89EQ37235818-62F152E1-6BAD-4790-BE24-DB6C7AC8BBC6Q37685642-19F6A8D5-4163-4820-90EB-B4F7C89BA586Q38716082-65D48A68-9388-431B-B1D2-8DB75C18C8C9Q39733620-EB189E6B-EC0B-4CA4-88BD-892576CAB6B5Q41771941-17FBBB04-865C-4EA4-AE33-4465646E16B6Q43974384-1AAADEA5-CCF6-4B76-A126-CA91C0582916Q44330789-9FCD0A1F-64FD-43F9-B88C-FFEAC281B647Q47642128-5AEB95CF-DB85-4353-936C-74AD8E04CD37Q51372570-EABDC729-E72F-41F7-83CC-832F23B4B2DAQ52272873-E9188D5C-4C7D-4108-B762-7C33095E737BQ53763250-EAB4DB04-630A-4E2A-A001-DDB858093384
P2860
Role of opioid antagonists in treating intravenous cocaine abuse.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Role of opioid antagonists in treating intravenous cocaine abuse.
@en
Role of opioid antagonists in treating intravenous cocaine abuse.
@nl
type
label
Role of opioid antagonists in treating intravenous cocaine abuse.
@en
Role of opioid antagonists in treating intravenous cocaine abuse.
@nl
prefLabel
Role of opioid antagonists in treating intravenous cocaine abuse.
@en
Role of opioid antagonists in treating intravenous cocaine abuse.
@nl
P2093
P1433
P1476
Role of opioid antagonists in treating intravenous cocaine abuse.
@en
P2093
P304
P356
10.1016/0024-3205(89)90589-4
P407
P577
1989-01-01T00:00:00Z